Series E Funding

What is Series E funding?

Series E funding is the fifth priced round of preferred stock a venture-backed company sells. The company amends its charter to authorize a new series, Series E Preferred Stock, prices it per share, and sells it to investors in a private placement. The letter records sequence only. It carries no legal or economic meaning by itself.

What is Series E financing?

Series E financing is the same event described in the language of the documents. Lawyers say financing because what happens is the authorization and sale of a new series of preferred stock, not a grant or a loan. Delaware law lets a corporation issue one or more classes of stock or one or more series within a class, with the rights of each series stated in the certificate of incorporation or in a board resolution filed as a certificate of designations. Series E is one of those series. Everything a reader cares about, the price, the liquidation preference, the anti-dilution formula, the board seat, lives in those documents, not in the letter E.

What does Series E funding mean for a company?

It means the company has priced equity five separate times and is still private. That is the only inference the letter supports. It does not tell you revenue, valuation, burn, or whether the last round was an up round. A company on its Series E may be a year from an initial public offering or may be recapitalizing after a bad two years, and the letter reads identically in both cases.

What is Series E?

Series E is the name of a share class, in exactly the way Series A and Series B are. When a company raises again, counsel creates a new series so the new money can have its own price per share, its own liquidation preference, and its own protective provisions without disturbing the earlier series. After the fourth such event the next one is E. That is the whole derivation.

Is Series E funding bad?

No, and the question is usually a proxy for a different one: was the round priced up or down, and on what terms. Those are the facts that matter, and they are visible in the charter rather than in the letter.

Cooley, which papers a large share of United States venture financings, reported 166 venture financings in the second quarter of 2026 representing $85.7 billion of invested capital. In that quarter 83.6% of deals were up rounds, 4.3% were flat and 12.1% were down, against 86.6%, 2.5% and 10.9% in the first quarter. So a late round being a down round is a minority outcome but not a rare one. Cooley also reported that Series D and later rounds showed the greatest decrease in median pre-money valuation in that quarter, dropping from $2.4 billion in the first quarter to $600 million in the second, which is a reminder that the late-stage median is driven by a handful of very large deals and moves violently quarter to quarter.

Three things make a late round genuinely bad news, and none of them is the letter:

• A price per share below the prior series, which triggers anti-dilution adjustment and resets employee option economics.
• Structure layered on top of price. Cooley reported that 95.8% of deals in the quarter carried a 1x liquidation preference, so multiple preferences remain unusual; the percentage of deals with pay-to-play provisions rose from 7% to 8.4%, and a pay-to-play is a direct signal that existing holders were unwilling to fund.
• A round raised because the company has no other option, which shows up as a very short runway in the diligence file rather than anywhere in the documents.

A Series E raised at a higher price, with a 1x non-participating preference and no new structure, is simply a company that needed more capital and could get it.

What is Series H funding? What is Series M funding?

Series H

Series H is the eighth series of preferred stock a company has authorized. Nothing changes at H. The same certificate of incorporation mechanics that created Series A create Series H, and Delaware imposes no ceiling on the number of series a corporation may have.

Series M

Series M is the thirteenth. It is rare enough that most people encounter the phrase only in coverage of a handful of very heavily financed private companies. Two cautions. First, some companies skip or reuse letters for reasons that have nothing to do with sequence, including a series named for a specific investor tranche or a recapitalization that renames earlier classes. Second, Series M is sometimes used loosely in press coverage as shorthand for a mezzanine or pre-IPO round, which is a different idea entirely and is not a defined term in any charter.

How a Series E round is actually papered

The document set is the same one used at Series A, adjusted. The National Venture Capital Association publishes Model Legal Documents for venture financings, describing them as the industry-embraced model documents to be used in venture capital financings; the set includes a Certificate of Incorporation, a Stock Purchase Agreement, an Investors' Rights Agreement, a Voting Agreement, and a Right of First Refusal and Co-Sale Agreement. At Series E the work is mostly editing rather than drafting: the charter gains a Series E designation with its price, preference and conversion terms, and the four agreements gain Series E holders as parties.

The round is a private placement. Almost all of them rely on Rule 506 of Regulation D. Rule 506(b) permits no more than 35 non-accredited purchasers in any 90-calendar-day period and forbids general solicitation; Rule 506(c) permits general solicitation but requires that all purchasers be accredited investors and that the issuer take reasonable steps to verify that they are. Either way the company must file a Form D. Rule 503 requires the notice no later than 15 calendar days after the first sale of securities in the offering, with the deadline rolling to the next business day if it falls on a weekend or holiday.

Late rounds also commonly close in tranches, with a second closing conditioned on a milestone. That is worth knowing because it makes the headline number and the cash actually received different things.

A worked example, from an actual filing

Parabilis Medicines disclosed its Series E in the registration statement on Form S-1/A it filed with the Securities and Exchange Commission on June 9, 2026. The filing states that in February 2024 the company issued and sold an aggregate of 12,445,024 shares of Series E convertible preferred stock at a price per share of $6.2281 for an aggregate purchase price of approximately $77.5 million, and that in January 2025 it issued and sold an additional 10,836,539 shares at the same $6.2281 per share in a second closing for approximately $67.5 million.

Check the arithmetic on both legs:

• First closing: 12,445,024 x $6.2281 = $77,508,853.97, which rounds to the $77.5 million disclosed.
• Second closing: 10,836,539 x $6.2281 = $67,491,048.55, which rounds to the $67.5 million disclosed.
• Series E in total: 12,445,024 + 10,836,539 = 23,281,563 shares for $77,508,853.97 + $67,491,048.55 = $144,999,902.52, call it $145.0 million.

Then the interesting part. The same filing states that in January 2026 the company issued and sold 49,518,175 shares of Series F convertible preferred stock at a price per share of $6.1644 for approximately $305.2 million. Verify that leg too: 49,518,175 x $6.1644 = $305,249,837.97, which rounds to $305.2 million.

Compare the two prices per share. $6.1644 - $6.2281 = -$0.0637, and -$0.0637 / $6.2281 = -1.02%. The Series F cleared at about one percent below the Series E price, on more than twice the dollars, and the company filed to go public a few months later. That single company answers the "is Series E bad" question better than any generalization: the round after the Series E was technically a down round by a rounding error, raised more than twice as much capital, and preceded a public offering.

Common mistakes

• Reading the letter as a stage. Series E is a count of priced rounds, not a measure of maturity. A company that raised five small rounds and a company that raised two enormous ones can be at the same letter with nothing else in common.
• Comparing the headline round size to the cash received when the round has a second closing. Parabilis announced its Series E across two closings eleven months apart.
• Assuming a new letter means a new price. Extensions are frequently sold as additional shares of the existing series at the original price, which is why the same $6.2281 appears in both Series E closings above.
• Treating median late-stage valuations as a benchmark. As the Cooley quarter shows, that median moved from $2.4 billion to $600 million in three months because a small number of very large deals dominate the sample.
• Believing the alphabet caps out. It does not, in Delaware or anywhere else.

How it relates to adjacent terms

Series D funding is the round immediately before, papered identically, and the price per share of the Series D is the reference point that determines whether the Series E is an up round, a flat round or a down round. Anti-dilution protection is the clause that does something about it: if the Series E prices below the Series D, the conversion ratio of the earlier series adjusts, usually on a broad-based weighted-average formula. A down round is the named condition, and it is the thing people are actually asking about when they ask whether a late letter is bad.

One term further out, secondary market activity is what fills the gap a fifth priced round implies. A company on its Series E has employees holding options granted many years earlier, and tender offers and secondary sales exist because the letter kept advancing while the liquidity did not.

Related tools and reading

• Follow-On Reserve Calculator
• SAFE Calculator
• Best SPV Platforms
• Best Fund Administration Software